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Background:  The Reg gene has been reported to be expressed in regenerating islets and Reg1 protein to be up-regulated at an 
early stage of diabetes in mice. As human Reg1α is homologous with murine Reg1, we investigated whether common variants in 
Reg1α are associated with type 2 diabetes in the Korean population. 
Methods:  We sequenced the Reg1α gene to identify common polymorphisms using 24 Korean DNA samples. Of 11 polymor-
phisms found, five common ones (g.-385T>C [rs10165462], g.-36T>G [rs25689789], g.209G>T [rs2070707], g.1385C>G [novel], 
and g.2199G>A [novel]) were genotyped in 752 type 2 diabetic patients and 642 non-diabetic subjects. 
Results:  No polymorphism was associated with the risk of type 2 diabetes. However, g.-385C and g.2199A lowered the risk of ear-
ly-onset type 2 diabetes, defined as a diagnosis in subjects whose age at diagnosis was 25 years or more but less than 40 years (odds 
ratio [OR], 0.721 [0.535 to 0.971] and 0.731 [0.546 to 0.977] for g.-385C and g.2199A, respectively) and g.1385G increased the risk 
of early-onset diabetes (OR, 1.398 [1.055 to 1.854]). Although adjusting for errors in multiple hypotheses-testing showed no sta-
tistically significant association between the three individual polymorphisms and early-onset diabetes, the haplotype H1, com-
posed of g.-385C, g.1385C, and g.2199A, was associated with a reduced risk of early-onset diabetes (OR, 0.590 [0.396 to 0.877], P 
= 0.009). 
Conclusion:  Polymorphisms in the Reg1α were not found to be associated with overall susceptibility to type 2 diabetes, though 
some showed modest associations with early-onset type 2 diabetes in the Korean population.
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INTRODUCTION 
The Reg gene was discovered during the screening of a regen-
erating islet-derived cDNA library in mice [1]. In the rodent 
model, the Reg1 gene encodes a protein expressed in the pan-
creatic exocrine tissue and in regenerating islet [1,2]. Reg1 pro-
tein increased DNA synthesis in pancreatic beta cells [2,3] and 
ameliorated experimental diabetes in rats [2,4]. Non-obese di-
abetes (NOD) mice expressing Reg1 in beta cells showed a de-
lay in the onset of diabetes, whereas islets from Reg knockout 
mice showed a lower proliferative capacity [5], suggesting a pos-
sible role for this protein in replication, growth, and maturation 
of islet beta cells. A recent study showed that depletion of Reg1 
was associated with the pathogenesis of impaired glucose tol-
Original Article
Korean Diabetes J 2010;34:229-236
doi: 10.4093/kdj.2010.34.4.229
pISSN 1976-9180 · eISSN 2093-2650230
Koo BK, et al.
Korean Diabetes J 2010;34:229-236 www.e-kdj.org
erance of pancreatitis-associated diabetes [6] and furthermore, 
administration of Reg1 protein improved the insulin secretion 
capacity in a diabetic rat model [4,6], implying that Reg1α might 
play a role in the pathogenesis of type 2 diabetes. 
  In humans, four members of the Reg family have been dis-
covered: Reg1α, Reg1β, HIP/PAP, and the homologue of islet 
neogenesis-associated protein (IN-GAP) [7,8]. Of these, Reg1α 
is encoded by a gene located on chromosome 2p12, which is 
homologous to the mouse Reg1 gene [1]. Expression of the 
Reg1α gene has been found in pancreatic ductal cells, exocrine 
cells, and islet cells in human and is increased in type 2 diabetes 
compared to normal subjects [9], suggesting that Reg1α might 
play a role in the pathogenesis of type 2 diabetes in humans. How-
ever, the clinical implications of genetic variants of Reg1α are 
largely unknown. Only one previous study screened for the 
Reg1α gene by PCR-SSCP. This study used a very small number 
of subjects in Thailand and showed no association between a 
polymorphism in exon 1 and type 2 diabetes mellitus [10]. To 
more thoroughly investigate the possible association of Reg1α 
with type 2 diabetes, we searched for common variants in Reg1α 
among Korean populations, and investigated whether common 
variants in Reg1α are associated with type 2 diabetes in this pop-
ulation. 
METHODS
Subjects
We studied 752 unrelated patients with type 2 diabetes from the 
Diabetes Clinic of Seoul National University Hospital (age, 59 
± 10 years; 349 men, 403 women) and 642 non-diabetic con-
trol subjects (age, 65 ± 4 years; 288 men, 354 women). All sub-
jects in this study were of Korean ethnicity. Type 2 diabetes was 
diagnosed according to World Health Organization criteria 
[11] and subjects with positive GAD antibodies or with the mi-
tochondrial DNA 3243 mutation were excluded. Patients with 
type 2 diabetes were divided with into three subgroups accord-
ing to age at diagnosis, according to previous epidemiologic 
studies [12-14]: 1) early-onset diabetes (n = 119, subjects whose 
age at diagnosis was 25 years or more but less than 40 years; 70 
men, 49 women); 2) average-onset diabetes (n = 496, subjects 
whose age at diagnosis was 40 years or more but less than 60 
years; 223 men, 273 women); and 3) late-onset diabetes (n = 
137, subjects whose age at diagnosis was 60 years or more; 56 
men, 49 women). Genotype frequencies were compared among 
the non-diabetic, diabetic, early-onset diabetic, average-onset 
diabetic, and late-onset diabetic groups. Selection of the non-
diabetic control subjects was made according to the following 
criteria: 60 years old or older, no past history of diabetes, no di-
abetes in first-degree relatives, a fasting plasma glucose concen-
tration of less than 6.1 mmol/L, and an A1c level of less than 5.8%.
  The Institutional Review Board of the Clinical Research In-
stitute at Seoul National University Hospital approved the study 
protocol and informed consent for genetic analysis was obtained 
from each subject. 
  Each study subject was examined in the morning after an 
overnight fast. Height, weight, circumferences of waist and hip, 
and blood pressure were measured. Blood samples were drawn 
for biochemical measurements (fasting plasma glucose, fast-
ing plasma insulin, A1c, total cholesterol, triglyceride, and high 
density lipoprotein cholesterol) and DNA extraction. The clin-
ical characteristics of the study population are shown in Table 
1. Compared with the non-diabetic control subjects, patients 
with type 2 diabetes were younger and had a higher mean body 
mass index (BMI), higher waist circumference, higher systolic 
blood pressure, and higher fasting plasma glucose and fasting 
triglyceride levels.
Identification of polymorphisms of human Reg1α and 
genotyping 
Twenty-four DNA samples from Korean subjects for initial se-
quencing were randomly selected from unrelated local resi-
dents with no history of familial disease. We sequenced all ex-
ons and exon-intron boundaries including the promoter region 
(~1.5 kb) to discover polymorphisms in these 24 Korean DNA 
samples using an ABI PRISM 3730 DNA analyzer (Applied 
Biosystems, Foster City, CA, USA). Eight primer sets of Reg1α 
were designed for the amplification and sequencing analysis 
based on GenBank sequences (Ref. Genome seq. for REG1A; 
NT_022184). Sequence variants were verified by chromato-
grams.
  Genotyping polymorphic sites with fluorescence polariza-
tion detection was performed using TaqMan [15] as described 
in a previous study [16]. Genotyping quality control was per-
formed in 10% of samples by duplicate checking (rate of con-
cordance of duplicates was > 99%).
Statistical analyses
All data were analyzed using SPSS/Win programs (SPSS Inc., 
Chicago, IL, USA). Results are presented as means ± standard 
deviation. Variables not normally distributed were logarithmi-231
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cally transformed before statistical analysis. The χ2 test was used 
to determine whether individual polymorphisms were in Har-
dy-Weinberg equilibrium (P > 0.05). We examined a widely used 
measure of linkage disequilibrium (LD) between all pairs of 
biallelic loci, Lewontin’s D´ (|D´|) [17], and r
2. Haplotypes and 
their frequencies were inferred using the algorithm developed 
by Stephens et al. [18]. Logistic regression analysis was used 
for calculating odds ratios (ORs), 95% confidence interval, and 
corresponding P values, after controlling for age, sex, and BMI 
as covariates. Genotypes were given codes of 0, 1, and 2 in the 
additive model; 0, 1, and 1 in the dominant model; or 0, 0, and 
1 in the recessive model, respectively. In the additive model, the 
OR was expressed per difference in number of rare alleles. Mul-
tiple regressions were used for the association analyses of dia-
betes-related phenotypes. Only non-diabetic subjects were used 
for the association analyses of metabolic phenotypes, as treat-
ment for type 2 diabetes can affect phenotypic values in diabet-
ics. For adjusting errors in multiple hypotheses-testing, we used 
the false discovery rate (FDR) [19]. The FDR was applied to the 
sex- and BMI-adjusted multivariate models examining the ad-
ditive effect of each gene polymorphism. Haplotype associations 
were also estimated using PHASE, which was used to construct 
a haplotype for each subject with the greatest probability, based 
on Bayesian statistics [18]. P values of <0.05 were considered 
statistically significant. 
RESULTS
Identification of polymorphisms in the Reg1α gene 
From the DNA samples of 24 Koreans, 11 single nucleotide 
polymorphisms (SNPs) were identified in the Reg1α gene (Fig. 
1). Five common variants (g.-385T>C [rs10165462], g.-36T>G 
[rs25689789], g.209G>T [rs2070707], g.1385C>G [novel], and 
g.2199G>A [novel)] were selected a for larger-scale genotyp-
ing based on location (SNPs in exon and promoter were pre-
ferred), LD (only one SNP if there are absolute LDs [γ
2 > 0.9]) 
[20], frequency (> 0.05), and haplotype tagging status [21]. The 
genotype distributions of all loci in the Reg1α gene were in Har-
dy-Weinberg equilibrium (P > 0.05). 
Association with type 2 diabetes 
We assessed the associations between each genotype and type 
2 diabetes by logistic regression analyses adjusting for age, sex, 
and BMI. No polymorphism was found to be associated with 
Table 1.  Clinical characteristics of the study subjects
Control
(n = 642)
Type 2 diabetes
(n = 752)
P value 
a
Sex, M/F   288/354 349/403
Age, yr 65 ± 4 60 ± 10 < 0.001
Age at diagnosis of diabetes, yr 50 ± 10
Duration of diabetes 9 (0 to 43)
BMI, kg/m
2 23.6 ± 3.1 24.5 ± 2.9 < 0.001
Waist, M/F, cm 81.5 (60.0 to 100.0)/83.0 (56.0 to 106.0) 88.5 (68.5 to 119.0)/86.0 (62.5 to 112.0) < 0.001
Systolic blood pressure, mm Hg 127 (87 to 203) 132 (88 to 200) < 0.001
Diastolic blood pressure, mm Hg 79 (51 to 120) 80 (36 to 120) 0.388
Fasting plasma glucose, mmol/L 5.0 (3.7 to 6.0) 8.0 (3.7 to 24.1) < 0.001
Fasting insulin, pmol/L 7.8 ± 4.9 12.7 ± 12.3 < 0.001
HbA1c, % 5.3 (4.0 to 5.8) 7.8 (4.2 to 15.0) < 0.001
Cholesterol, mmol/L 4.9 (2.5 to 8.7) 5.1 (1.9 to 9.3) 0.007
Triglyceride, mmol/L 1.3 (0.4 to 5.9) 1.6 (0.4 to 12.5) < 0.001
HDL-C, mmol/L 1.2 (0.5 to 2.5) 1.2 (0.1 to 2.6) 0.001
Data are given as means ± standard deviation for normally distributed variables, and otherwise as medians (range).
P values of BMI and waist circumference were adjusted for age and sex. P values of blood pressure, fasting plasma glucose, plasma insulin, 
HbA1c, and lipid profiles were adjusted for age, sex, and BMI.
BMI, body mass index; HDL-C, high density lipoprotein cholesterol.
aP values for differences between control group and type 2 diabetes.232
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the risk of type 2 diabetes (Table 2). Next, we examined the as-
sociation between the Reg1α gene polymorphisms and age at 
diagnosis of type 2 diabetes. g.1385G was more frequently 
found in cases of early-onset diabetes, defined as mentioned 
above, than in the control group (sex and BMI-adjusted OR, 
1.398 [1.055 to 1.854]; P = 0.020 in the additive model) (Table 
2). In contrast, g.-385C and g.2199A were associated with a 
decreased risk of early-onset type 2 diabetes with ORs of 0.721 
(0.535 to 0.971) (P = 0.031) and 0.731 (0.546 to 0.977) (P = 0.035), 
respectively in the additive model. However, when the FDR 
was used to adjust for errors from multiple comparisons, these 
effects lost statistical significance (Table 2).
  Five common haplotypes (frequency > 0.05) were identified 
with the five polymorphisms genotyped in the Reg1α gene, 
which accounted for 96.7% of all observed haplotypes. No hap-
lotype was found to be associated with type 2 diabetes in the 
additive or recessive models (Table 3). However, the haplotype 
H1 (C-T-G-C-A), consisting of g.-385C, g.1385C, and g.2199A, 
decreased the risk of early-onset diabetes (sex and BMI-adjust-
ed OR, 0.590 [0.396 to 0.877]; P = 0.009) and the haplotype H2 
(T-T-G-G-G), consisting of g.-385T, g.1385G, and g.2199G in-
creased the risk of early-onset diabetes (sex and BMI-adjusted 
Fig. 1.  (A) Map of the Reg1α gene on chromosome 2p12 with polymorphisms which were identified in 24 Korean DNA sam-
ples. Single nucleotide polymorphisms in bold were selected for sequencing in all subjects. (B) Linkage disequilibrium among 
Reg1α polymorphisms. r
2 is a measure of the correlation between alleles at two sites and is calculated by dividing by the product 
of the four allele frequencies at the two loci.; |D´| = D/Dmax (D represents disequilibrium coefficient and Dmax is the largest 
possible value of D). 
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OR, 1.644 [1.091 to 2.538], P = 0.018) in the dominant model 
(Table 3). 
Association with diabetes-related phenotypes 
For the association analysis of the diabetes-related phenotypes, 
only non-diabetic subjects were used because, as mentioned 
above, treatment for diabetes can affect the measured parame-
ters. We found that none of the metabolic phenotypes, includ-
ing fasting plasma glucose, triglyceride, fasting plasma insulin, 
homeostasis model assessment of insulin resistance (HOMA-
IR), and HOMA-beta cell function, were associated with any 
individual polymorphism (data not shown).
 
DISCUSSION 
In this study, we identified 11 SNPs in the Reg1α gene but found 
that no SNP was associated with susceptibility to type 2 diabetes 
mellitus. However, the g.-385T>C, g.1385C>G, and g.2199G>A 
SNPs seemed to be associated with early-onset diabetes; g.1385G 
increased the risk of early-onset diabetes and g.-385C and 
g.2199A decreased this risk. Although FDR showed no statis-
tical significance for the associations between those polymor-
phisms and early-onset diabetes, the haplotype H1 composed 
of g.-385C, g.1385C, and g.2199A was found to be associated 
with a reduced risk of early-onset diabetes. 
  Reg1 protein is thought to be a stimulator of beta cell prolif-
eration and neogenesis [2,3]. The fact that Reg1 affects the pro-
liferation of beta cells only in the early stage of diabetes and that 
Reg1 level is reduced during overt stage diabetes [22] suggest 
that Reg gene expression may be important during develop-
ment of diabetes mellitus in the early stage. In support of this 
possibility, it has been shown in the NOD mouse model that 
Table 2.  Association between polymorphisms in the Reg1α gene and the risk of type 2 diabetes
Control,
count (%)
Type 2 diabetes, count (%) OR (95% CI) 
FDR
g
Total 
Early-
onset
a
Average-
onset
b
Late-
onset
c OR
d OR
e OR
f
g.-385T>C
(rs10165462)
TT 242 (38.0) 295 (39.4) 59 (50.0) 185 (37.4) 51 (37.5) 0.984 
(0.845 to 
1.146)
0.721
h
(0.535 to 
0.971)
1.040
(0.887 to 
1.220)
TC 295 (46.3) 333 (44.5) 45 (38.1) 225 (45.5) 63 (46.3) 0.490
CC 100 (15.7) 121 (16.2) 14 (11.9) 85 (17.2) 22 (16.2)
g.-36T>G
(rs25689789)
TT 625 (97.4) 729 (97.1) 115 (96.6) 483 (97.4) 131 (96.3) 1.119
(0.583 to 
2.145)
1.426 
(0.466 to 
4.367)
1.069
(0.539 to 
2.117)
TG 17 (2.6) 22 (2.9) 4 (3.4) 13 (2.6) 5 (3.7) 0.994
GG
g.209G>T
(rs2070707)
GG 439 (68.6) 510 (67.9) 86 (72.3) 318 (64.1) 106 (77.9) 1.011 
(0.830 to
1.232)
0.844 
(0.580 to 
1.230)
1.037
(0.844 to 
1.274)
GT 178 (27.8) 218 (29.0) 29 (24.4) 163 (32.9) 26 (19.1) 0.994
TT 23 (3.6) 23 (3.1) 4 (3.4) 15 (3.0) 4 (2.9)
g.1385C>G
CC 278 (43.4) 308 (41.1) 37 (31.4) 222 (44.8) 49 (36.0) 1.025
(0.876 to 
1.199)
1.398
h 
(1.055 to 
1.854)
0.967
(0.821 to
1.140)
CG 278 (43.4)  345 (46.1) 60 (50.8) 215 (43.4) 70 (51.5) 0.490
GG 84 (13.1) 96 (12.8) 21 (17.8) 58 (11.7) 17 (12.5)
g.2199G>A
GG 225 (35.2)  265 (35.4) 54 (45.8) 169 (34.2) 42 (30.7)  0.996
(0.857 to
1.159)
0.731
h 
(0.546 to 
0.977)
1.054
(0.900 to 
1.234)
AG 299 (46.7)  350 (46.7) 49 (41.5) 232 (47.0) 69 (50.4) 0.490
AA 116 (18.1)  134 (17.9) 15 (12.7) 93 (18.8) 26 (19.0)
Genotype distributions are shown as numbers (%). Odds ratio (OR), 95% confidence interval (CI), and P values were obtained by logistic re-
gression analyses. ORs are expressed per difference in number of rare alleles using an additive model. 
Type 2 diabetic patients were divided into three subgroups according to age at diagnosis. 
ORs are expressed per difference in number of rare alleles using an additive model after controlling for sex and body mass index (BMI).
FDR, false discovery rate.
a‘Early onset’ was defined as diabetic subjects with the age at diagnosis of 25 ≤ < 40, 
bAverage-onset included subjects with age at diagnosis of 40 ≤ 
< 60, 
cand age at diagnosis of  ≥ 60 years was considered late-onset, 
dOR between control and all type 2 diabetes patients, 
eOR between normal 
controls and early-onset diabetes patients, 
fOR between normal controls and subjects with average- and late-onset diabetes, 
gFDR, adjusting for 
multiple comparisons in the multivariate binary regression analyses of additive effects of polymorphisms in early-onset diabetes compared to 
control subjects, 
hP value < 0.05.234
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overexpression of Reg1 in beta cells delayed the onset of diabe-
tes [5].
  At this time, however, it is not clear how Reg1α g.-385T>C, 
g.1385C>G, and g.2199G>A affect the development of diabe-
tes. Reg1α g.-385C is in a gene regulatory region and might be 
one of the E-box DNA elements (CANNTG: C with underline 
corresponds with g.-385C) and it is possible that this element 
could bind with basic helix-loop-helix (bHLH) transcription 
factors such as NeuroD and USF-1 [23]. Since there has been 
some debate as to whether Reg1α g.-385T>C is in the promot-
er area or not, we performed 5´ rapid amplification of cDNA 
ends (RACE)-PCR [24] to confirm its location. We found that 
Reg1α g.-385 is located in the 5´ untranslated region (data not 
shown). Recently, pancreas-derived cells exposed to Reg1 were 
reported to grow by activation of the signal transduction path-
way involving the mitogen-activated protein kinase phophatas-
es (MKP-1) and cyclins, with concomitant induction of MKP-1 
[25]. The mechanisms of association between the identified 
SNPs in Reg1α and early-onset diabetes will need to be eluci-
dated in independent studies.
  In conclusion, individual polymorphisms in the Reg1α gene 
were not statistically associated with an overall susceptibility 
to either type 2 diabetes or early-onset diabetes. Although the 
modest association identified between SNPs of Reg1α and ear-
ly-onset diabetes in the haplotype association study must be 
interpreted with caution, the comprehensive search for SNPs 
by re-sequencing and the examination of the clinical implica-
tions of SNPs of Reg1α in a Korean population are novel. Fur-
ther studies with a larger number of subjects in a more diverse 
population are needed to conclusively elucidate the associa-
tion between genetic polymorphisms in Reg1α and diabetes. 
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Table 3.  Association between haplotypes and the risk of early-onset diabetes
Haplotype Genotype
Control, 
count (%)
Type 2 diabetes, count (%) OR (95% CI)
P value
f
Early- onset
a Other
b OR
c OR
d OR
e
H1 CTGCA
-/- 246 (38.3) 61 (51.3) 239 (37.8) 0.926
(0.744 to
1.153)
0.590
(0.396 to
0.877)
1.014
(0.806 to
1.276)
0.009 -/H1 299 (46.6) 44 (37.0) 287 (45.3)
H1/H1 97 (15.1) 14 (11.8) 107 (16.9)
H2 TTGGG
-/- 278 (43.3) 37 (31.1) 274 (43.3) 1.047
(0.843 to
1.301)
1.664
(1.091 to
2.538)
0.971
(0.775 to
1.217)
0.018 -/H2 280 (43.6) 61 (51.3) 284 (44.9)
H2/H2 84 (13.1) 21 (17.6) 75 (11.8)
H3 TTTCG
-/- 442 (68.8) 86 (72.3) 426 (67.3) 1.032
(0.820 to
1.300)
0.811
(0.523 to
1.259)
1.067
(0.839 to
1.356)
0.351 -/H3 177 (27.6) 29 (24.4) 188 (29.7)
H3/H3 23 (3.6) 4 (3.4) 19 (3.0)
H4 TTGCG
-/- 573 (90.5) 103 (86.6) 573 (90.5) 0.879
(0.624 to 
1.240)
1.201
(0.669 to
2.157)
0.824
(0.572 to
1.187)
0.540 -/H4 57 (9.0) 16 (13.4) 57 (9.0)
H4/H4 3 (0.5) 3 (0.5)
H5 TTGCA
-/- 621 (96.7) 115 (96.6) 612 (96.7) 1.049
(0.579 to
1.903)
1.060
(0.354 to
3.172)
1.040
(0.559 to
1.937)
0.917 -/H5 21 (3.3) 4 (3.4) 21 (3.3)
H5/H5
Each haplotype with a frequency of > 0.05 is shown. The genotype of each haplotype is shown according to the sequence: g.-385, g.-36, g.209, 
g.1385, and g.2199.
OR, odds ratio; CI, confidence interval.
a‘Early onset’ was defined as the diabetic subjects with the age at diagnosis of 25 ≤ < 40, 
b‘Other’ was defined as the diabetic subjects with the age 
at diagnosis of 40 years or more, 
cOR between control and all type 2 diabetes patients after controlling for sex and body mass index (BMI) using 
the dominant model, 
dOR between normal controls and early-onset diabetes patients after controlling for sex and BMI using the dominant 
model, 
eOR between normal controls and the other diabetes patients after controlling for sex and BMI using the dominant model, 
fP values 
were obtained by logistic regression analyses in the dominant model controlling for sex and BMI as covariates.235
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